LBP AM’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Hold |
2,317
| – | – | ﹤0.01% | 363 |
|
|
2025
Q1 | $256K | Sell |
2,317
-22,816
| -91% | -$2.52M | ﹤0.01% | 360 |
|
|
2024
Q4 | $3.43M | Sell |
25,133
-4,733
| -16% | -$646K | 0.05% | 232 |
|
|
2024
Q3 | $3.44M | Buy |
29,866
+22,883
| +328% | +$2.64M | 0.05% | 212 |
|
|
2024
Q2 | $961K | Buy |
6,983
+383
| +6% | +$52.7K | 0.04% | 233 |
|
|
2024
Q1 | $910K | Buy |
+6,600
| New | +$910K | 0.04% | 257 |
|
|
2023
Q1 | – | Sell |
-1,820
| Closed | -$217K | – | 474 |
|
|
2022
Q4 | $217K | Buy |
+1,820
| New | +$217K | 0.01% | 449 |
|